NRG BR004-A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer

November 21, 2019
https://clinicaltrials.gov/ct2/show/NCT03199885
Cancer - Breast
Principal Investigator: Haythem Y Ali, MD
Brest cancer, HER2 positive, metastatic breast cancer
Accepting Participants
313-916-2438